|
Q1 FY2021
As of Mar 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q3 FY2020
As of Sep 30, 2020
|
|
|---|---|---|---|
| ASSETS | |||
| Deferred offering costs | |||
| Current assets | |||
| Cash | |||
| Prepaid expenses | |||
| Total Current Assets | |||
| Cash and marketable securities held in Trust Account | |||
| Total Assets | |||
| LIABILITIES AND SHAREHOLDERS' EQUITY | |||
| Current liabilities | |||
| Accrued expenses | |||
| Promissory note – related party | |||
| Total Current Liabilities | |||
| Accrued offering costs | |||
| Warrant Liabilities | |||
| Total Liabilities | |||
| Class A ordinary shares subject to possible redemption, 21,366,185 and 20,189,024, shares at redemption value at March 31, 2021 and December 31, 2020, respectively | |||
| Shareholders' Equity | |||
| Ordinary shares | |||
| Class A ordinary Shares | |||
| Class B ordinary Shares | |||
| Total ordinary shares | |||
| Class B ordinary shares, $0.0001 par value; 50,000,000 shares authorized; 6,468,750 shares issued and outstanding | |||
| Additional paid-in capital | |||
| Accumulated deficit | |||
| Class A ordinary Shares | |||
| Class B ordinary Shares | |||
| Total Shareholders' Equity | |||
| Total Liabilities and Shareholders' Equity |
Loading...
